Gene Page: EXPH5
Summary ?
GeneID | 23086 |
Symbol | EXPH5 |
Synonyms | SLAC2-B|SLAC2B |
Description | exophilin 5 |
Reference | MIM:612878|HGNC:HGNC:30578|Ensembl:ENSG00000110723|HPRD:08341|Vega:OTTHUMG00000166536 |
Gene type | protein-coding |
Map location | 11q22.3 |
Pascal p-value | 0.079 |
Fetal beta | -1.393 |
DMG | 1 (# studies) |
eGene | Myers' cis & trans |
Gene in Data Sources
Gene set name | Method of gene set | Description | Info |
---|---|---|---|
CV:GWASdb | Genome-wide Association Studies | GWASdb records for schizophrenia | |
CV:PGCnp | Genome-wide Association Study | GWAS | |
DMG:Wockner_2014 | Genome-wide DNA methylation analysis | This dataset includes 4641 differentially methylated probes corresponding to 2929 unique genes between schizophrenia patients (n=24) and controls (n=24). | 1 |
GSMA_I | Genome scan meta-analysis | Psr: 0.006 |
Section I. Genetics and epigenetics annotation
Differentially methylated gene
Probe | Chromosome | Position | Nearest gene | P (dis) | Beta (dis) | FDR (dis) | Study |
---|---|---|---|---|---|---|---|
cg16988008 | 11 | 108463728 | EXPH5 | 2.341E-4 | -0.161 | 0.037 | DMG:Wockner_2014 |
eQTL annotation
SNP ID | Chromosome | Position | eGene | Gene Entrez ID | pvalue | qvalue | TSS distance | eQTL type |
---|---|---|---|---|---|---|---|---|
rs17572651 | chr1 | 218943612 | EXPH5 | 23086 | 0 | trans | ||
rs16829545 | chr2 | 151977407 | EXPH5 | 23086 | 8.41E-23 | trans | ||
rs3845734 | chr2 | 171125572 | EXPH5 | 23086 | 0.01 | trans | ||
rs7584986 | chr2 | 184111432 | EXPH5 | 23086 | 5.761E-10 | trans | ||
rs9810143 | chr3 | 5060209 | EXPH5 | 23086 | 0.03 | trans | ||
rs16860529 | chr3 | 185900368 | EXPH5 | 23086 | 0.18 | trans | ||
rs363082 | chr4 | 3132712 | EXPH5 | 23086 | 0.09 | trans | ||
snp_a-1815771 | 0 | EXPH5 | 23086 | 0.04 | trans | |||
rs335980 | chr4 | 173329784 | EXPH5 | 23086 | 0.16 | trans | ||
rs17762315 | chr5 | 76807576 | EXPH5 | 23086 | 0.16 | trans | ||
rs10491487 | chr5 | 80323367 | EXPH5 | 23086 | 0.2 | trans | ||
rs11738579 | chr5 | 95119841 | EXPH5 | 23086 | 0.14 | trans | ||
rs13360496 | 0 | EXPH5 | 23086 | 0.15 | trans | |||
rs13191953 | chr6 | 24151042 | EXPH5 | 23086 | 0.11 | trans | ||
rs12196880 | chr6 | 24313746 | EXPH5 | 23086 | 0.05 | trans | ||
rs10806988 | chr6 | 24341768 | EXPH5 | 23086 | 0.11 | trans | ||
rs16890367 | chr6 | 38078448 | EXPH5 | 23086 | 0.05 | trans | ||
rs1929769 | chr6 | 40765977 | EXPH5 | 23086 | 0.15 | trans | ||
rs3118341 | chr9 | 25185518 | EXPH5 | 23086 | 0.07 | trans | ||
rs9406868 | chr9 | 25223372 | EXPH5 | 23086 | 0.09 | trans | ||
rs11139334 | chr9 | 84209393 | EXPH5 | 23086 | 4.214E-4 | trans | ||
rs3765543 | chr9 | 134458323 | EXPH5 | 23086 | 0.05 | trans | ||
rs2393316 | chr10 | 59333070 | EXPH5 | 23086 | 0 | trans | ||
rs9989228 | chr14 | 37809252 | EXPH5 | 23086 | 0.19 | trans | ||
rs16955618 | chr15 | 29937543 | EXPH5 | 23086 | 5.848E-34 | trans | ||
rs2077735 | chr15 | 58479024 | EXPH5 | 23086 | 0.09 | trans | ||
rs12914345 | chr15 | 77670400 | EXPH5 | 23086 | 0.19 | trans | ||
rs11873184 | chr18 | 1584081 | EXPH5 | 23086 | 0.05 | trans | ||
rs17761686 | chr18 | 56647634 | EXPH5 | 23086 | 0.09 | trans | ||
rs7274477 | chr20 | 1676942 | EXPH5 | 23086 | 0.08 | trans | ||
rs1041786 | chr21 | 22617710 | EXPH5 | 23086 | 5.048E-5 | trans | ||
rs16990575 | chrX | 32691327 | EXPH5 | 23086 | 0.17 | trans |
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
Top 10 positively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
SRGAP1 | 0.94 | 0.92 |
ZBED4 | 0.93 | 0.96 |
NHSL1 | 0.93 | 0.85 |
IL17RD | 0.93 | 0.94 |
ZNF462 | 0.92 | 0.94 |
ASXL3 | 0.92 | 0.91 |
FRMD4B | 0.92 | 0.84 |
BEND3 | 0.92 | 0.93 |
MYST4 | 0.92 | 0.96 |
BCL7A | 0.92 | 0.93 |
Top 10 negatively co-expressed genes | ||
Gene | Pearson's Correlation | Spearman's Correlation |
FBXO2 | -0.66 | -0.68 |
LHPP | -0.65 | -0.59 |
AIFM3 | -0.65 | -0.76 |
C5orf53 | -0.65 | -0.79 |
HLA-F | -0.65 | -0.76 |
ALDOC | -0.65 | -0.72 |
ACOT13 | -0.64 | -0.76 |
LDHD | -0.64 | -0.67 |
TSC22D4 | -0.63 | -0.78 |
CLU | -0.63 | -0.68 |
Section III. Gene Ontology annotation
Molecular function | GO term | Evidence | Neuro keywords | PubMed ID |
---|---|---|---|---|
GO:0005515 | protein binding | IEA | - | |
GO:0017137 | Rab GTPase binding | IEA | - | |
Biological process | GO term | Evidence | Neuro keywords | PubMed ID |
GO:0006886 | intracellular protein transport | IEA | - |
Section V. Pathway annotation
Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
---|---|---|---|
DAVICIONI TARGETS OF PAX FOXO1 FUSIONS DN | 68 | 49 | All SZGR 2.0 genes in this pathway |
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL UP | 450 | 256 | All SZGR 2.0 genes in this pathway |
JAEGER METASTASIS DN | 258 | 141 | All SZGR 2.0 genes in this pathway |
UDAYAKUMAR MED1 TARGETS UP | 135 | 82 | All SZGR 2.0 genes in this pathway |
DODD NASOPHARYNGEAL CARCINOMA UP | 1821 | 933 | All SZGR 2.0 genes in this pathway |
COLDREN GEFITINIB RESISTANCE DN | 230 | 115 | All SZGR 2.0 genes in this pathway |
WATTEL AUTONOMOUS THYROID ADENOMA UP | 73 | 47 | All SZGR 2.0 genes in this pathway |
NUYTTEN NIPP1 TARGETS DN | 848 | 527 | All SZGR 2.0 genes in this pathway |
FERREIRA EWINGS SARCOMA UNSTABLE VS STABLE DN | 98 | 59 | All SZGR 2.0 genes in this pathway |
BENPORATH NANOG TARGETS | 988 | 594 | All SZGR 2.0 genes in this pathway |
BENPORATH SOX2 TARGETS | 734 | 436 | All SZGR 2.0 genes in this pathway |
ONDER CDH1 TARGETS 2 DN | 464 | 276 | All SZGR 2.0 genes in this pathway |
FLECHNER BIOPSY KIDNEY TRANSPLANT REJECTED VS OK DN | 546 | 351 | All SZGR 2.0 genes in this pathway |
MOREAUX MULTIPLE MYELOMA BY TACI UP | 412 | 249 | All SZGR 2.0 genes in this pathway |
BROWNE HCMV INFECTION 16HR UP | 225 | 139 | All SZGR 2.0 genes in this pathway |
BLALOCK ALZHEIMERS DISEASE UP | 1691 | 1088 | All SZGR 2.0 genes in this pathway |
DAZARD RESPONSE TO UV NHEK DN | 318 | 220 | All SZGR 2.0 genes in this pathway |
BAELDE DIABETIC NEPHROPATHY DN | 434 | 302 | All SZGR 2.0 genes in this pathway |
DAZARD UV RESPONSE CLUSTER G6 | 153 | 112 | All SZGR 2.0 genes in this pathway |
LEIN CEREBELLUM MARKERS | 85 | 47 | All SZGR 2.0 genes in this pathway |
ACEVEDO METHYLATED IN LIVER CANCER DN | 940 | 425 | All SZGR 2.0 genes in this pathway |
BOCHKIS FOXA2 TARGETS | 425 | 261 | All SZGR 2.0 genes in this pathway |
BOHN PRIMARY IMMUNODEFICIENCY SYNDROM UP | 47 | 30 | All SZGR 2.0 genes in this pathway |
BOYAULT LIVER CANCER SUBCLASS G123 DN | 51 | 30 | All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS CTNNB1 UP | 176 | 110 | All SZGR 2.0 genes in this pathway |
CHIANG LIVER CANCER SUBCLASS INTERFERON DN | 52 | 30 | All SZGR 2.0 genes in this pathway |
YAGI AML WITH INV 16 TRANSLOCATION | 422 | 277 | All SZGR 2.0 genes in this pathway |
MIKKELSEN MEF ICP WITH H3K27ME3 | 206 | 108 | All SZGR 2.0 genes in this pathway |
FOURNIER ACINAR DEVELOPMENT LATE 2 | 277 | 172 | All SZGR 2.0 genes in this pathway |
ACOSTA PROLIFERATION INDEPENDENT MYC TARGETS UP | 84 | 51 | All SZGR 2.0 genes in this pathway |
LEE BMP2 TARGETS UP | 745 | 475 | All SZGR 2.0 genes in this pathway |
ZWANG TRANSIENTLY UP BY 1ST EGF PULSE ONLY | 1839 | 928 | All SZGR 2.0 genes in this pathway |